Business Description
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -91.6 | |||||
3-Year EPS without NRI Growth Rate | -91.6 | |||||
3-Year FCF Growth Rate | -80.7 | |||||
3-Year Book Growth Rate | 49.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.18 | |||||
9-Day RSI | 44.35 | |||||
14-Day RSI | 43.6 | |||||
6-1 Month Momentum % | 11.56 | |||||
12-1 Month Momentum % | -3.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.3 | |||||
Shareholder Yield % | -10.63 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -161.66 | |||||
ROA % | -130.6 | |||||
ROIC % | -471.12 | |||||
ROCE % | -161.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.16 | |||||
Price-to-Tangible-Book | 10.6 | |||||
EV-to-EBIT | -3.4 | |||||
EV-to-EBITDA | -3.4 | |||||
EV-to-FCF | -3.64 | |||||
Price-to-Net-Current-Asset-Value | 114 | |||||
Earnings Yield (Greenblatt) % | -29.41 | |||||
FCF Yield % | -26.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Abera Bioscience AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -35.14 | ||
Beta | 0 | ||
Volatility % | 65.54 | ||
14-Day RSI | 43.6 | ||
14-Day ATR (kr) | 0.346766 | ||
20-Day SMA (kr) | 4.7635 | ||
12-1 Month Momentum % | -3.09 | ||
52-Week Range (kr) | 3.05 - 7.5 | ||
Shares Outstanding (Mil) | 14.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abera Bioscience AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abera Bioscience AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Abera Bioscience AB Frequently Asked Questions
What is Abera Bioscience AB(XSAT:ABERA)'s stock price today?
When is next earnings date of Abera Bioscience AB(XSAT:ABERA)?
Does Abera Bioscience AB(XSAT:ABERA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |